emrosi

Generic: minocycline hydrochloride extended-release

Labeler: journey medical corporation
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name emrosi
Generic Name minocycline hydrochloride extended-release
Labeler journey medical corporation
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

minocycline hydrochloride 40 mg/1

Manufacturer
Journey Medical Corporation

Identifiers & Regulatory

Product NDC 69489-131
Product ID 69489-131_335d912c-9d84-1e78-e063-6294a90aa2f9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA219015
Listing Expiration 2026-12-31
Marketing Start 2025-03-01

Pharmacologic Class

Classes
decreased prothrombin activity [pe] tetracycline-class drug [epc] tetracyclines [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69489131
Hyphenated Format 69489-131

Supplemental Identifiers

RxCUI
2706371 2706378
UPC
0369489131071
UNII
0020414E5U

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name emrosi (source: ndc)
Generic Name minocycline hydrochloride extended-release (source: ndc)
Application Number NDA219015 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 40 mg/1
source: ndc
Packaging
  • 7 CAPSULE in 1 BOTTLE (69489-131-07)
  • 30 CAPSULE in 1 BOTTLE (69489-131-30)
source: ndc

Packages (2)

69489-131-07 7 CAPSULE in 1 BOTTLE (69489-131-07) 69489-131-30 30 CAPSULE in 1 BOTTLE (69489-131-30)

Ingredients (1)

minocycline hydrochloride (40 mg/1)

Linked Drug Pages (1)

EMROSI ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "335d912c-9d84-1e78-e063-6294a90aa2f9", "openfda": {"upc": ["0369489131071"], "unii": ["0020414E5U"], "rxcui": ["2706371", "2706378"], "spl_set_id": ["0899eb25-8807-037c-f66c-141a2696b1c0"], "manufacturer_name": ["Journey Medical Corporation"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "7 CAPSULE in 1 BOTTLE (69489-131-07)", "package_ndc": "69489-131-07", "marketing_start_date": "20250310"}, {"sample": false, "description": "30 CAPSULE in 1 BOTTLE (69489-131-30)", "package_ndc": "69489-131-30", "marketing_start_date": "20250301"}], "brand_name": "EMROSI", "product_id": "69489-131_335d912c-9d84-1e78-e063-6294a90aa2f9", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Prothrombin Activity [PE]", "Tetracycline-class Drug [EPC]", "Tetracyclines [CS]"], "product_ndc": "69489-131", "generic_name": "Minocycline Hydrochloride Extended-Release", "labeler_name": "Journey Medical Corporation", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "EMROSI", "active_ingredients": [{"name": "MINOCYCLINE HYDROCHLORIDE", "strength": "40 mg/1"}], "application_number": "NDA219015", "marketing_category": "NDA", "marketing_start_date": "20250301", "listing_expiration_date": "20261231"}